LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 WZ-4-145
10.0
uM
LJP6
 0.4554 0.0797 0.2151 0.1013
BT-20 XMD16-144
10.0
uM
LJP5
 0.2714 0.0357 -0.0576 0.0710
BT-20 Brivanib
10.0
uM
LJP5
 0.8477 0.0136 0.7790 0.0212
BT-20 Buparlisib
10.0
uM
LJP5
 0.1498 0.0166 -0.2331 0.0489
BT-20 BX-912
10.0
uM
LJP5
 0.5243 0.0421 0.3088 0.0713
BT-20 Canertinib
10.0
uM
LJP6
 0.2481 0.0399 -0.0874 0.0372
BT-20 Celastrol
10.0
uM
LJP6
 0.1313 0.0221 -0.2584 0.0296
BT-20 CGP60474
10.0
uM
LJP5
 0.1440 0.0379 -0.2420 0.0746
BT-20 CGP60474
10.0
uM
LJP6
 0.1020 0.0161 -0.3023 0.0492
BT-20 CHIR-99021
10.0
uM
LJP6
 0.8789 0.0768 0.8288 0.1087
BT-20 CP724714
10.0
uM
LJP5
 0.6450 0.0263 0.4866 0.0310
BT-20 CP466722
10.0
uM
LJP5
 0.6849 0.1021 0.5492 0.1409
BT-20 Crizotinib
10.0
uM
LJP5
 0.2855 0.0086 -0.0360 0.0322
BT-20 Momelotinib
10.0
uM
LJP5
 0.3453 0.0349 0.0518 0.0475
BT-20 Dasatinib
10.0
uM
LJP5
 0.2665 0.0173 -0.0630 0.0317
BT-20 Dasatinib
10.0
uM
LJP6
 0.1966 0.0077 -0.1645 0.0275
BT-20 Dovitinib
10.0
uM
LJP5
 0.3986 0.0346 0.1280 0.0570
BT-20 Enzastaurin
10.0
uM
LJP5
 1.1895 0.0305 1.2746 0.0438
BT-20 Erlotinib
10.0
uM
LJP5
 0.6559 0.0162 0.5008 0.0308
BT-20 Foretinib
10.0
uM
LJP5
 0.2476 0.0211 -0.0915 0.0518
BT-20 R406
10.0
uM
LJP6
 0.5707 0.1282 0.3852 0.1771
BT-20 Pictilisib
10.0
uM
LJP6
 0.2825 0.0270 -0.0384 0.0204
BT-20 Gefitinib
10.0
uM
LJP6
 0.7927 0.0581 0.7028 0.0792
BT-20 Geldanamycin
10.0
uM
LJP5
 0.2047 0.0231 -0.1525 0.0382
BT-20 Geldanamycin
10.0
uM
LJP6
 0.1925 0.0269 -0.1706 0.0494